Change provisions relating to blood tests for pregnant women
Summary
LB41 updates Nebraska’s communicable disease statutes to change the state’s rules for blood testing of pregnant women. The bill keeps the existing syphilis screening framework but revises the language to clarify that pregnant women must be informed that the test is voluntary and may be declined verbally or in writing. It also adds a new requirement that physicians or other authorized obstetric providers administer or arrange for an HIV blood test during pregnancy unless the patient has given written informed consent declining the test.
The bill also addresses how the cost of certain syphilis tests is handled for people covered under the Medical Assistance Act. It states legislative intent that, when a syphilis test for a covered individual was not previously covered, the cost should be paid from the Medicaid Managed Care Excess Profit Fund and federal funds. Finally, LB41 repeals the original statute it replaces, making the revised provisions the operative law.
Impact
LB41 amends Nebraska Revised Statutes governing prenatal blood testing by adding HIV screening requirements and clarifying informed-consent procedures for syphilis testing. It affects physicians, obstetric providers, approved laboratories, the Department of Health and Human Services, and pregnant patients. The bill also creates a funding directive for certain Medicaid-related syphilis testing costs, potentially shifting payment responsibility to the Medicaid Managed Care Excess Profit Fund and federal matching funds.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It advanced and passed with unanimous or near-unanimous votes at each recorded stage, including 47-0 on final reading. The voting history suggests the Legislature viewed the measure as a routine public health update rather than a controversial policy change.
Contention
No major contention is reflected in the available record. The only issues that could have prompted discussion are the expansion of prenatal testing to include HIV and the requirement that patients be informed the test is voluntary and may be refused, but the vote totals indicate these provisions were not divisive. The funding language tying some testing costs to the Medicaid Managed Care Excess Profit Fund and federal funds may have been a technical or fiscal point of interest, but no opposition is shown in the provided materials.